TREATMENT
Ginkgo biloba did not prevent dementia or Alzheimer disease in elderly people
| The first 150 words of the full text of this article appear below. |
S T DeKosky
Dr S T DeKosky, University of Virginia School of Medicine, Charlottesville, VA, USA; dekosky@virginia.edu
Does Ginkgo biloba reduce incident dementia and Alzheimer disease in elderly people with normal cognition or mild cognitive impairment?
Design: randomised placebo controlled trial (Ginkgo Evaluation of Memory [GEM] study). ClinicalTrials.gov NCT00010803 [ClinicalTrials.gov] .
Allocation: unclear allocation concealment.*
Blinding: blinded (patients, clinicians, and outcome assessors).*
Follow-up period: median 6.1 years.
Setting: 5 academic medical centres in the USA.
Participants:
3069 participants >75 years of age (mean age 79 y, 54% men) who had normal cognition or mild cognitive impairment (impaired at
10th percentile of Cardiovascular Health Study normative data on 2 of 10 neuropsychological tests and Clinical Dementia Rating global score of 0.5). Exclusion criteria included dementia; bleeding disorders; Parkinson disease; receipt of warfarin, cholinesterase inhibitors, antidepressants, or antipsychotics; abnormal thyroid tests, serum creatinine concentration >2 mg/dl (>176.8 µmol/l), or liver function test result
HeSAS, University of Glamorgan, Pontypridd, Wales, UK
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
